Eric Innes, MD
Pain Medicine · Orem, UTNPI 1841618444
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,470 of the $3,632 with a category attached, or 68.0%. 15 manufacturers reported payments, led by Relievant Medsystems, Inc. at 38.8% of the total. Reporting peaked in 2023 at $1,551 and has fallen 77.6% since, to $348 in 2025. That places this record below the midpoint for pain medicine clinicians in UT, where the typical reported total is $3,451.
Across 66 payments — averaging $55.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$1K
- Boston Scientific$548
- Nevro Corp.$517
- Medtronic$389
- Avanos Medical$143
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$123
- plus $505 from 9 others
What the payments were for
- Travel & lodging$1,16232%
- Food & beverage$2,47068%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 14 | $1,408 |
| Boston Scientific | 12 | $548 |
| Nevro Corp. | 9 | $517 |
| Medtronic(2 entities) | 4 | $389 |
| Avanos Medical | 1 | $143 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $123 |
| Averitas Pharma Inc. | 5 | $120 |
| Zimmer Biomet | 1 | $105 |
| Orthofix Medical, Inc. | 3 | $79 |
| Abbott | 3 | $60 |
| Vertex | 2 | $48 |
| Globus Medical | 1 | $26 |
| Stryker | 1 | $25 |
| SPR Therapeutics, Inc | 2 | $23 |
| AbbVie | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,632 in reported general payments places this provider in the 50th percentile of 61 pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 434 | $11,143 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 227 | $5,348 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 122 | $3,249 |
| Meloxicam | 386 | $2,962 |
| Methocarbamol | 155 | $2,599 |
| Diclofenac Sodium | 136 | $2,588 |
| Lidocaine | 27 | $2,443 |
| Pregabalin | 136 | $2,061 |
| Celecoxib | 82 | $1,959 |
| Duloxetine Hcl | 46 | $1,572 |
| Cyclobenzaprine Hcl | 127 | $1,469 |
| Tramadol Hcl | 128 | $1,238 |
| Tizanidine Hcl | 88 | $1,233 |
| Oxycodone Hcl | 46 | $1,053 |
| Nortriptyline Hcl | 38 | $856 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Orem
- Maria SchwartzSalt Lake City$813K
- Jeremy JoyalDraper$170K
- Lynn WebsterSalt Lake City$160K
- Benjamin HumpherysLayton$120K
- Derek HaightDraper$78K
- Jon ObraySt George$24K
- Jason BeckstrandWest Jordan$17K
- Austin AlbrightSalt Lake City$14K
- Jeffrey PenceWest Valley City$13K
- Braden WebbDraper$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.